R J Polzer

804 total citations
10 papers, 608 citations indexed

About

R J Polzer is a scholar working on Pharmacology, Molecular Biology and Epidemiology. According to data from OpenAlex, R J Polzer has authored 10 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 4 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in R J Polzer's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (3 papers) and Cancer therapeutics and mechanisms (2 papers). R J Polzer is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Resistance in Bacteria (3 papers) and Cancer therapeutics and mechanisms (2 papers). R J Polzer collaborates with scholars based in United States and United Kingdom. R J Polzer's co-authors include Jing Lin, Jinghai J. Xu, Steven M. Winter, S L Haskell, Patrice Courvalin, Thomas D. Gootz, D Girard, Jacques Tankovic, Richard P. Zaniewski and Paul H. Edelstein and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Chemico-Biological Interactions.

In The Last Decade

R J Polzer

10 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R J Polzer United States 9 217 213 159 135 89 10 608
Virna Schuck United States 12 165 0.8× 302 1.4× 170 1.1× 311 2.3× 57 0.6× 17 591
N. A. KUCK United States 12 189 0.9× 242 1.1× 48 0.3× 121 0.9× 25 0.3× 21 550
Marion Flipo France 18 501 2.3× 106 0.5× 158 1.0× 139 1.0× 93 1.0× 30 962
Richard A. Mueller United States 17 423 1.9× 154 0.7× 92 0.6× 50 0.4× 74 0.8× 34 1.2k
Robert E. Desjardins United States 14 169 0.8× 103 0.5× 116 0.7× 32 0.2× 111 1.2× 18 948
Masaya Takei Japan 15 346 1.6× 264 1.2× 162 1.0× 246 1.8× 24 0.3× 22 772
Anil K. Saksena United States 18 407 1.9× 194 0.9× 175 1.1× 64 0.5× 19 0.2× 58 1.2k
Eugenia N. Olsufyeva Russia 19 350 1.6× 246 1.2× 110 0.7× 83 0.6× 29 0.3× 50 770
Robert L. Charnas Switzerland 15 433 2.0× 421 2.0× 149 0.9× 682 5.1× 21 0.2× 20 1.1k
Emilio Lence Spain 14 252 1.2× 83 0.4× 36 0.2× 137 1.0× 32 0.4× 47 480

Countries citing papers authored by R J Polzer

Since Specialization
Citations

This map shows the geographic impact of R J Polzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J Polzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J Polzer more than expected).

Fields of papers citing papers by R J Polzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R J Polzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J Polzer. The network helps show where R J Polzer may publish in the future.

Co-authorship network of co-authors of R J Polzer

This figure shows the co-authorship network connecting the top 25 collaborators of R J Polzer. A scholar is included among the top collaborators of R J Polzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J Polzer. R J Polzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Avery, Lindsay B., Mengmeng Wang, Alison Joyce, et al.. (2016). Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies. mAbs. 8(6). 1064–1078. 70 indexed citations
2.
Lin, Jing, et al.. (2003). The Role of Absorption, Distribution, Metabolism, Excretion and Toxicity in Drug Discovery. Current Topics in Medicinal Chemistry. 3(10). 1125–1154. 221 indexed citations
3.
Vincent, John, Jürgen Venitz, Rongyue Teng, et al.. (1997). Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 75–80. 59 indexed citations
4.
Johnson, Nancy J., et al.. (1997). A study of the phototoxic potential of trovafloxacin in BALB/c mice. Journal of Antimicrobial Chemotherapy. 39(suppl 2). 67–73. 22 indexed citations
5.
Thadepalli, H, et al.. (1997). In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli. Antimicrobial Agents and Chemotherapy. 41(3). 583–586. 28 indexed citations
6.
Khan, Anis A., Teri R. Slifer, Fausto G. Araujo, R J Polzer, & Jack S. Remington. (1997). Activity of trovafloxacin in combination with other drugs for treatment of acute murine toxoplasmosis. Antimicrobial Agents and Chemotherapy. 41(5). 893–897. 17 indexed citations
7.
Thadepalli, H, et al.. (1997). Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice. Antimicrobial Agents and Chemotherapy. 41(9). 1933–1936. 14 indexed citations
8.
Gootz, Thomas D., Richard P. Zaniewski, S L Haskell, et al.. (1996). Activity of the new fluoroquinolone trovafloxacin (CP-99,219) against DNA gyrase and topoisomerase IV mutants of Streptococcus pneumoniae selected in vitro. Antimicrobial Agents and Chemotherapy. 40(12). 2691–2697. 114 indexed citations
9.
Edelstein, Paul H., M A Edelstein, Jie Ren, R J Polzer, & Ronald P. Gladue. (1996). Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with L. pneumophila pneumonia. Antimicrobial Agents and Chemotherapy. 40(2). 314–319. 57 indexed citations
10.
Polzer, R J, Stephanie L. Coffing, Craig B. Marcus, et al.. (1995). Inhibition of benzo[a]pyrene metabolism by insulin, FITC-insulin and an FITC-insulin-antibody conjugate in the human hepatoma cell line HepG2. Chemico-Biological Interactions. 97(3). 307–318. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Virna Schuck Breakdown of academic impact, for papers by N. A. KUCK Breakdown of academic impact, for papers by Marion Flipo Breakdown of academic impact, for papers by Richard A. Mueller Breakdown of academic impact, for papers by Robert E. Desjardins Breakdown of academic impact, for papers by Masaya Takei Breakdown of academic impact, for papers by Anil K. Saksena Breakdown of academic impact, for papers by Eugenia N. Olsufyeva Breakdown of academic impact, for papers by Robert L. Charnas Breakdown of academic impact, for papers by Emilio Lence
Rankless by CCL
2026